Axa S.A. Regeneron Pharmaceuticals, Inc. Transaction History

Axa S.A.

$32.2 Billion
Q4 2024

A detailed history of Axa S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Axa S.A. holds 80,364 shares of REGN stock, worth $56.2 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

80,364

Previous 86,777 7.39%

Holding current value

$56.2 Million

Previous $91.2 Million 37.25%

% of portfolio

0.18%

Previous 0.28%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$701.85 - $1046.91 $4.5 Million - $6.71 Million	-6,413 Reduced 7.39%	80,364 $57.2 Million
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $6.02 Million - $7.06 Million	-5,877 Reduced 6.34%	86,777 $91.2 Million
Q2 2024 Feb 25, 2025	BUY	$883.2 - $1071.19 $10.9 Million - $13.2 Million	12,290 Added 15.29%	92,654 $97.4 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $7.51 Million - $9.1 Million	-8,499 Reduced 8.4%	92,654 $97.4 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $8.42 Million - $9.26 Million	-9,324 Reduced 8.44%	101,153 $97.4 Million
Q4 2023 Jul 16, 2024	BUY	$775.18 - $881.7 $7.23 Million - $8.22 Million	9,324 Added 9.22%	110,477 $97 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $2.76 Million - $3.14 Million	-3,564 Reduced 3.13%	110,477 $97 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $474,328 - $578,393	685 Added 0.6%	114,041 $93.9 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $19.9 Million - $23.6 Million	-28,381 Reduced 20.02%	113,356 $81.5 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $17.7 Million - $21.5 Million	-26,010 Reduced 15.51%	141,737 $116 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $29.3 Million - $31.8 Million	41,500 Added 32.87%	167,747 $121 Million
Q3 2022 Feb 14, 2023	SELL	$573.97 - $724.32 $2.77 Million - $3.49 Million	-4,818 Reduced 3.68%	126,247 $87 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $2.77 Million - $3.49 Million	-4,818 Reduced 3.68%	126,247 $87 Million
Q2 2022 Feb 14, 2023	SELL	$548.35 - $738.84 $1.96 Million - $2.64 Million	-3,576 Reduced 2.66%	131,065 $77.5 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $1.96 Million - $2.64 Million	-3,576 Reduced 2.66%	131,065 $77.5 Million
Q1 2022 Feb 14, 2023	BUY	$595.12 - $698.43 $5 Million - $5.86 Million	8,394 Added 6.65%	134,641 $94 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $21.7 Million - $25.4 Million	-36,434 Reduced 21.3%	134,641 $94 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $14.1 Million - $17.4 Million	-26,003 Reduced 13.19%	171,075 $108 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $42.9 Million - $50.9 Million	74,696 Added 61.04%	197,078 $119 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $7.4 Million - $8.74 Million	-15,653 Reduced 11.34%	122,382 $68.4 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $6.52 Million - $8 Million	14,590 Added 11.82%	138,035 $65.3 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $953,251 - $1.21 Million	-1,993 Reduced 1.59%	123,445 $59.6 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $4.3 Million - $5.2 Million	7,896 Added 6.72%	125,438 $70.2 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $16.9 Million - $22 Million	34,201 Added 41.04%	117,542 $73.3 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $3.51 Million - $5.16 Million	-10,438 Reduced 11.13%	83,341 $40.7 Million
Q4 2019 Feb 18, 2020	BUY	$274.13 - $376.51 $12.5 Million - $17.2 Million	45,751 Added 95.26%	93,779 $35.2 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $505,900 - $589,021	-1,850 Reduced 3.71%	48,028 $13.3 Million
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $6.67 Million - $9.24 Million	-22,279 Reduced 30.88%	49,878 $15.6 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $511,610 - $604,408	1,375 Added 1.94%	72,157 $29.6 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $7.46 Million - $8.95 Million	-22,201 Reduced 23.88%	70,782 $26.4 Million
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $313,344 - $379,833	1,101 Added 1.2%	92,983 $32.1 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $409,302 - $510,338	-1,296 Reduced 1.39%	91,882 $31.6 Million
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $101,492 - $132,995	-283 Reduced 0.3%	93,178 $35 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $40.3 Million - $47.1 Million	93,461	93,461 $41.8 Million

Others Institutions Holding REGN

# of Institutions

1,493

Shares Held

85.8M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account